KR100260061B1 - Vitamin e drop - Google Patents

Vitamin e drop Download PDF

Info

Publication number
KR100260061B1
KR100260061B1 KR1019930008884A KR930008884A KR100260061B1 KR 100260061 B1 KR100260061 B1 KR 100260061B1 KR 1019930008884 A KR1019930008884 A KR 1019930008884A KR 930008884 A KR930008884 A KR 930008884A KR 100260061 B1 KR100260061 B1 KR 100260061B1
Authority
KR
South Korea
Prior art keywords
vitamin
salts
ester
surfactant
preservative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930008884A
Other languages
English (en)
Korean (ko)
Other versions
KR940005269A (ko
Inventor
Yoichi Kawashima
Mitsuaki Kuwano
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of KR940005269A publication Critical patent/KR940005269A/ko
Application granted granted Critical
Publication of KR100260061B1 publication Critical patent/KR100260061B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019930008884A 1992-05-26 1993-05-22 Vitamin e drop Expired - Fee Related KR100260061B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP92-133193 1992-05-26
JP13319392 1992-05-26

Publications (2)

Publication Number Publication Date
KR940005269A KR940005269A (ko) 1994-03-21
KR100260061B1 true KR100260061B1 (en) 2000-07-01

Family

ID=15098888

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930008884A Expired - Fee Related KR100260061B1 (en) 1992-05-26 1993-05-22 Vitamin e drop

Country Status (11)

Country Link
US (1) US5559157A (enExample)
EP (1) EP0572190B1 (enExample)
JP (1) JP2811036B2 (enExample)
KR (1) KR100260061B1 (enExample)
CN (1) CN1053807C (enExample)
AT (1) ATE169815T1 (enExample)
CA (1) CA2096902A1 (enExample)
DE (1) DE69320405T2 (enExample)
DK (1) DK0572190T3 (enExample)
ES (1) ES2121948T3 (enExample)
TW (1) TW266154B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
EP0708646A1 (en) * 1994-05-06 1996-05-01 Alcon Laboratories, Inc. Use of vitamin e tocopheryl derivatives in ophthalmic compositions
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5811453A (en) * 1994-12-23 1998-09-22 Alcon Laboratories, Inc. Viscoelastic compositions and methods of use
US5798356A (en) * 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US6379688B2 (en) 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
ES2180976T3 (es) * 1997-04-25 2003-02-16 Schering Plough Kabushiki Kais Colirio conteniendo un metabolito de loratidina.
US6226118B1 (en) 1997-06-18 2001-05-01 Olympus Optical Co., Ltd. Optical microscope
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
US6906858B2 (en) 2000-07-17 2005-06-14 Olympus Optical Co., Ltd. Microscope provided with an objective lens focusing apparatus and an objective lens switching apparatus
US7989503B2 (en) * 2002-05-22 2011-08-02 Nihon Pharmaceutical Co., Ltd. Smooth muscle peristole inhibitor
JP4789479B2 (ja) * 2004-02-23 2011-10-12 ロート製薬株式会社 プラノプロフェン含有水性組成物
DE102004045622A1 (de) * 2004-09-17 2006-03-30 Aquanova German Solubilisate Technologies (Agt) Gmbh Konservierungsmittel-Zusammensetzungen
US9993558B2 (en) * 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
BRPI0708585B1 (pt) * 2006-03-07 2017-02-21 Aquanova Ag solubilizado livre de agente de estabilização, processo para a preparação e uso do mesmo
EP2043628A4 (en) * 2006-06-27 2009-11-25 Riolan Technologies Inc ULTRAVIOLET ABSORBENT OPHTHALMIC COMPOSITIONS
CN101278908B (zh) * 2008-05-18 2010-10-13 程浩文 一种左氧氟沙星滴眼液
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2306684A1 (fr) * 1975-04-11 1976-11-05 Crinex Lab Nouvelle composition a action immunostimulante
JPS60246695A (ja) * 1984-05-22 1985-12-06 松下電器産業株式会社 印刷配線板の製造方法
JPH0737381B2 (ja) * 1987-05-15 1995-04-26 参天製薬株式会社 ビタミンｅ水性製剤
CA1333360C (en) * 1987-10-19 1994-12-06 Andrew S. Janoff Tocopherol-based pharmaceutical systems
JPH01106018A (ja) * 1987-10-20 1989-04-24 Asahi Glass Co Ltd 液晶表示素子

Also Published As

Publication number Publication date
ES2121948T3 (es) 1998-12-16
CN1085082A (zh) 1994-04-13
DE69320405T2 (de) 1999-01-14
EP0572190B1 (en) 1998-08-19
CN1053807C (zh) 2000-06-28
US5559157A (en) 1996-09-24
JP2811036B2 (ja) 1998-10-15
JPH0640910A (ja) 1994-02-15
KR940005269A (ko) 1994-03-21
DK0572190T3 (da) 1999-02-22
DE69320405D1 (de) 1998-09-24
EP0572190A1 (en) 1993-12-01
CA2096902A1 (en) 1993-11-27
ATE169815T1 (de) 1998-09-15
TW266154B (enExample) 1995-12-21

Similar Documents

Publication Publication Date Title
KR100260061B1 (en) Vitamin e drop
DE69221463T2 (de) Eine komposition und ein verfahren zur identifizierung von einer lösung
IL87724A (en) Ophthalmic compositions,their preparation and use
AU4438489A (en) Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
AU575612B2 (en) (piperidine-4-yl-amino)-benzimidazoles/imida-20 pyrines
NL950022I2 (nl) Analoga van mevalolacton en derivaten daarvan, werkwijzen voor hun bereiding, farmaceutische prepar aten die ze bevatten en hun toepassing als farmaceutica.
AU7797887A (en) Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
TW234691B (enExample)
IL109534A0 (en) Pour-on formulations containing polymeric material, glycols and glycerides and a process for their preparation
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
EP0497001A3 (en) Oxidized-type glutathione alkyl ester
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
IT1245717B (it) Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
PT862433E (pt) Composicao farmaceutica espumante topica para o tratamento de dermatoses induzidas por pityrosporum oval
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
AU2001242398A1 (en) Contact lens treating method and composition
JPS55102516A (en) Remedy for glaucoma
DE3168004D1 (en) Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof
TH13559A (th) องค์ประกอบทางเภสัชที่ใช้ในการรักษาโรคต้อหิน
JPS55162718A (en) Remedy for glaucoma
GR3018349T3 (en) Use of naproxen as mydriatic agent.
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20030404

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20030404

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000